Simon Dingemans

Last updated

Simon Paul Dingemans (born April 1963) [1] is an English former banker and businessman. Until May 2019 he was chief financial officer at GlaxoSmithKline. In July 2019 he was appointed chair of the Financial Reporting Council, and was set to lead its transition into the Audit, Reporting and Governance Authority, but left in May 2020.

Contents

Education

Dingemans was educated at Kent College and Christ Church, Oxford where he gained a master's degree in geography. [2] [3] He was involved in theatre production at the Oxford Playhouse. [4]

Career

Dingemans joined S. G. Warburg & Co. as a graduate trainee, spending 15 years with the firm before moving to Goldman Sachs to run its UK investment banking and European mergers businesses. [4]

Dingemans spent 25 years at Goldman Sachs, becoming head of European mergers and acquisitions, and overseeing £411 billion ($500 billion) of deals, including Vodafone's £112bn merger with Mannesmann in 2000, the private equity takeover of Alliance Boots, and Novartis's $28.1bn (£18.2bn) takeover of Alcon. [5]

In 2011, he joined GlaxoSmithKline as CFO [5] and served as a member of the main board before stepping down in May 2019. During his eight years at GSK, he oversaw extensive restructuring and re-shaping of the group. [6]

In July 2019 Business Secretary Greg Clark announced that Dingemans had been appointed as the new chair of the Financial Reporting Council, and would lead its transition into the Audit, Reporting and Governance Authority. [2] However, he left the role in May 2020, citing conflicts between the part-time role and other positions he was interested in taking. [7]

In June 2020 Dingemans joined Carlyle Group as a managing director in charge of UK buyouts and overseeing healthcare deals across Europe. [7] [8]

Non-executive roles

Dingemans was chairman of the Hundred Group of finance directors between 2014 and 2016. [2] He was appointed a trustee of the Donmar Warehouse theatre in 2018, [9] having previously done theatre production at the Oxford Playhouse and also supported the Royal National Theatre. [4]

He is an investor in wealth management firm Netwealth Investments. [10] [11] [12]

Personal life

Dingemans is married with three children. He has participated in triathlons. [3]

Related Research Articles

Creative accounting Euphemism referring to unethical accounting practices

Creative accounting is a euphemism referring to accounting practices that may follow the letter of the rules of standard accounting practices, but deviate from the spirit of those rules with questionable accounting ethics—specifically distorting results in favor of the "preparers", or the firm that hired the accountant. They are characterized by excessive complication and the use of novel ways of characterizing income, assets, or liabilities and the intent to influence readers towards the interpretations desired by the authors. The terms "innovative" or "aggressive" are also sometimes used. Another common synonym is "cooking the books". Creative accounting is oftentimes used in tandem with outright financial fraud, and lines between the two are blurred. Creative accounting practices are known since ancient times and appear world-wide in various forms.

GlaxoSmithKline British pharmaceutical company

GlaxoSmithKline plc (GSK) is a British multinational pharmaceutical company headquartered in London, England. Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, GSK was the world's sixth largest pharmaceutical company according to Forbes as of 2019, after Pfizer, Novartis, Roche, Sanofi, and Merck & Co. GSK is the tenth largest pharmaceutical company and #296 on the 2019 Fortune 500, ranked behind other pharmaceutical companies including China Resources, Johnson & Johnson, Roche, Sinopharm, Pfizer, Novartis, Bayer, Merck, and Sanofi.

Goldman Sachs U.S. multinational investment bank

The Goldman Sachs Group, Inc., is an American multinational investment bank and financial services company headquartered in New York City. It offers services in investment management, securities, asset management, prime brokerage, and securities underwriting. It also provides investment banking to institutional investors.

FTSE 100 Index Share index of the London Stock Exchange

The Financial Times Stock Exchange 100 Index, also called the FTSE 100 Index, FTSE 100, FTSE, or, informally, the "Footsie", is a share index of the 100 companies listed on the London Stock Exchange with the highest market capitalisation. It is seen as a gauge of prosperity for businesses regulated by UK company law. The index is maintained by the FTSE Group, a subsidiary of the London Stock Exchange Group.

Peter Oppenheimer is the former senior vice president and Chief Financial Officer of Apple Inc and has been a member of the board of directors of Goldman Sachs since 2014.

Lloyd Blankfein American investment banker

Lloyd Craig Blankfein is an American investment banker who has served as senior chairman of Goldman Sachs since 2019, and chairman and chief executive from 2006 until the end of 2018. Previous to leading Goldman Sachs, he was the company's president and chief operating officer (COO) from 2004 to 2006, serving under then-CEO Hank Paulson.

John Lawson Thornton is an American businessman and professor and director of the Global Leadership Program at Tsinghua University in Beijing. He is also executive chairman of Barrick Gold Corporation and non-executive chairman of PineBridge Investments. Thornton stepped down as co-president of Goldman Sachs in 2003.

Financial Reporting Council

The Financial Reporting Council (FRC) is an independent regulator in the UK and Ireland, responsible for regulating auditors, accountants and actuaries, and setting the UK's Corporate Governance and Stewardship Codes. The FRC seeks to promote transparency and integrity in business by aiming its work at investors and others who rely on company reports, audits and high-quality risk management.

Sir Philip Roy Hampton is a British businessman. He was the first chair of UK Financial Investments Limited in 2008 and chair of government-owned Royal Bank of Scotland Group between 2009 and 2015. He has also chaired GlaxoSmithKline and J Sainsbury.

John Michael Evans is a Canadian technology executive and the President of Alibaba Group. He previously spent 20 years working for U.S. investment bank Goldman Sachs and is a former Olympic rower.

London Stock Exchange Group British financial services company

London Stock Exchange Group plc (LSEG) is a British-based stock exchange and financial information company. It is headquartered in London, England. It owns the London Stock Exchange, Refinitiv, LSEG Technology, FTSE Russell, and majority stakes in LCH and Tradeweb.

Andrew Witty Pharmaceutical executive

Sir Andrew Philip Witty is a British business executive, who was the chief executive officer (CEO) of GlaxoSmithKline between 2008 and 2017. Witty was succeeded by Emma Walmsley on 1 April 2017. He formerly held the role of Chancellor of the University of Nottingham.

Block Drug Pharmaceutical company

Block Drug Company was a pharmaceutical company based in Jersey City, New Jersey, United States, that specialized in dental care products. Its most popular products included Polident denture cleanser, Poli-Grip denture adhesive, Dentu-Creme denture toothpaste, Nytol sleeping pill, Tegrin medicated shampoo for psoriasis, Lava hand soaps, Beano and Phazyme anti-gas products, Balmex diaper rash ointments, and Sensodyne desensitizing toothpaste.

David Alan Viniar was the CFO and executive vice president at Goldman Sachs from 1999 until January 31, 2013. He is currently on the board of directors of Goldman Sachs.

The pharmaceutical industry in the United Kingdom directly employs around 73,000 people and in 2007 contributed £8.4 billion to the UK's GDP and invested a total of £3.9 billion in research and development. In 2007 exports of pharmaceutical products from the UK totalled £14.6 billion, creating a trade surplus in pharmaceutical products of £4.3 billion.

Harvey M. Schwartz is an American investment banker who served as the president and co-chief operating officer of Goldman Sachs from 2017 to his retirement in 2018. He previously served as chief financial officer, in which capacity he was succeeded by R. Martin Chavez in May 2017.

Anthony Noto is an American businessman, the CEO of SoFi, and the former COO of Twitter.

Greenhill is an independent investment bank founded in 1996 by Robert F. Greenhill. The firm provides advice on mergers, acquisitions, restructurings, financings, and capital raisings to leading corporations, partnerships, institutions and governments across a number of industries.

Emma Walmsley British businesswoman

Dame Emma Natasha Walmsley is the chief executive officer (CEO) of GlaxoSmithKline. She succeeded Sir Andrew Witty, who retired in March 2017. Before GSK, she worked for L'Oréal for 17 years, and was a non-executive director of Diageo until September 2016. She grew up Barrow-in-Furness, Cumbria.

The Audit, Reporting and Governance Authority is a proposed audit regulator intended to be established in the United Kingdom to replace the Financial Reporting Council. The government announced plans for a new regulator in March 2019, and published detailed proposals in March 2021; the new regulator is expected to be fully implemented in 2023.

References

  1. "Simon Paul DINGEMANS". Companies House. Retrieved 23 July 2019.
  2. 1 2 3 "New Chair of Financial Reporting Council announced". Gov.uk - Department for Business, Energy & Industrial Strategy. 23 July 2019. Retrieved 23 July 2019.
  3. 1 2 Baker, Martin, 2 July 2006, The Rainmaker: Dingemans bags his prey Telegraph. Accessed: 15 June 2020
  4. 1 2 3 Jack, Andrew (15 December 2011). "Pharmaceutical giant gives new finance chief a soft landing". Financial Times. Retrieved 23 July 2019.
  5. 1 2 Graham, Ruddick (9 September 2010). "Goldman Sachs rainmaker Simon Dingemans to join GlaxoSmithKline". Telegraph. Retrieved 23 July 2019.
  6. Howard, Tom (9 May 2018). "GlaxoSmithKline CFO Simon Dingemans to retire next May". Proactive Investors. Retrieved 15 June 2020.
  7. 1 2 Carrick, Angharad (15 June 2020). "Former FRC chairman Simon Dingemans joins Carlyle". City AM. Retrieved 15 June 2020.
  8. FRC’s former chairman joins private equity firm Carlyle, Financial Times
  9. Hemley, Matthew (16 May 2018). "Martha Lane Fox joins Donmar Warehouse board". The Stage. Retrieved 23 July 2019.
  10. Foster, Mike. "Ex-Goldman bankers back City's newest robo-adviser" . Retrieved 2017-12-22.
  11. Goldsmith, Courtney (2017-09-19). "Wealth manager Netwealth raises £10m in second funding round" . Retrieved 2017-12-22.
  12. "Bonham Carter backs launch of online discretionary manager Netwealth". investmentweek.co.uk. Retrieved 2017-12-22.